Bashan Dror 4
4 · Protalix BioTherapeutics, Inc. · Filed Apr 3, 2024
Insider Transaction Report
Form 4
Bashan Dror
DirectorPRESIDENT AND CEO
Transactions
- Award
Common Stock
2024-04-01+263,960→ 2,149,418 total(indirect: By Trust)
Holdings
- 132,516
Common Stock
Footnotes (2)
- [F1]Represents fully-vested restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the Reporting Person under the Amended and Restated Protalix BioTherapeutics, Inc. 2006 Stock Incentive Plan, as amended (the "Plan").
- [F2]To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.